People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Berkeley Lights, Inc. | — | Biotechnology | Series C | $73.8M | $1.8B | 2016 |
| Prellis Biologics, Inc | — | Biotech / Pharma | Series B | $47.3M | $277.2M | 2021 |
Shaun Holt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Shaun Holt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Marks | 2 | 20 |
| Alex Morgan | 1 | 10 |
| Rohit Sharma | 1 | 10 |
| Michael Moritz | 1 | 7 |
| Igor Khandros | 1 | 3 |
| Arvind Gupta | 1 | 3 |
| William Davidow | 1 | 2 |
| Makoto Shintani | 1 | 2 |
| Stuart Merkadeau | 1 | 2 |
| Ming Wu | 1 | 2 |
| Lip-Bu Tan Tan | 1 | 1 |
| Sean O'Sullivan | 1 | 1 |
| Melanie Matheu | 1 | 1 |
| Lei Meng | 1 | 1 |
| Noelle Mullin | 1 | 1 |
| Andy Last | 1 | 1 |
| Eric Hobbs | 1 | 1 |
| John Gunn | 1 | 1 |
| James Rothman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.